Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Phase 3 Randomized Controlled Trial of NO Re-excision MelanomA - NORMA 2

NCT07530887 is registered in ClinicalTrials.gov with Marieke Goodijk as lead sponsor.

NCT NCT07530887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07530887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Phase 3 Randomized Controlled Trial of NO Re-excision MelanomA - NORMA 2
Lead sponsor
Marieke Goodijk
Phase
Phase 3
Overall status
Recruiting
Start date
November 13, 2025
Completion date
November 30, 2033
Enrollment
1,749 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin cancer)